A COVID-19 vaccine for people with B-cell deficiency

0

Those with B-cell deficiencies are still vulnerable following current COVID-19 vaccinations; however, researchers have created a new vaccine that targets T-cell response and works on immunocompromised people.

While the COVID-19 vaccine drive and mRNA vaccines have allowed life to return to normal for many, one group of people – those with compromised immune systems – have remained vulnerable and isolated. Researchers from the University Hospital Tübingen (Germany) have been working on a solution for people with humoral immunity deficiencies by targeting T cells and cell-mediated immunity.

READ MORE ON BIOTECHNIQUES NOW

Share:

Leave A Comment